In a bold move poised to trigger the deep state and disrupt the pharmaceutical establishment, Secretary of Health and Human Services Robert F. Kennedy Jr. is considering a major policy shift: removing the COVID-19 vaccine from the Centers for Disease Control and Prevention’s (CDC) recommended childhood immunization schedule.
The long-anticipated move could impact pediatric practices, insurance coverage, and school vaccine mandates, while also protecting American children from an ever-growing list of adverse events associated with an experimental shot that never should have been approved in the first place.
“Why are we giving this to tens of millions of kids when the vaccine itself does have profound risks? We’ve seen huge associations of myocarditis and pericarditis with strokes, with other injuries, with neurological injuries,” Kennedy told Jesse Waters during a Fox News interview. “We need to give people informed consent, and we shouldn’t be making recommendations that are not good for the population.”
Kennedy, a long-time advocate for vaccine safety and medical transparency, says there is insufficient scientific evidence to justify vaccinating healthy children, particularly when children face an almost nonexistent risk of severe COVID-19. His effort reflects a broader push to restore trust in public health institutions and to end what he calls the “capture” of federal health agencies by pharmaceutical interests. It also echoes the goals of his “Make America Healthy Again” movement, which aims to realign public health policy with evidence-based science rather than corporate profits.
While uptake of the COVID-19 vaccine among children remains historically low, public health officials who promoted the shots continue to sound alarms about any moves to reconsider their recommendations. However, Kennedy and a growing segment of the American public recognize the real crisis: collapsing public trust in health authorities that rushed to authorize vaccines for young children based on flimsy evidence and incomplete safety data.
Despite assurances during his confirmation hearings that he would not alter the CDC’s vaccine schedule, Kennedy has signaled his intent to challenge the status quo after revealing that he has deep concerns over industry influence on vaccine advisory panels, such as the CDC’s Advisory Committee on Immunization Practices and the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC).
The FDA unanimously voted 21-0 in June 2022 to recommend Pfizer and Moderna’s shots for infants and young children, stating that the totality of the evidence available showed the benefits of the vaccines outweighed the risks of use. Pfizer’s three-dose vaccine covers children 6 months to 5 years old, while Moderna’s two-dose vaccine covers children 6 months to 6 years old.
However, states had already ordered millions of doses that were made available prior to FDA authorization by the Biden administration. At the time, VRBPAC committee members ignored pleas from experts, the vaccine-injured, and a congressman representing 17 other lawmakers to halt authorization until questions about the safety and efficacy of COVID-19 vaccines for the nation’s youngest children could be properly addressed.
In approving the shot for kids, VRBPAC relied primarily on studies with small sample sizes, short follow-up periods, and questionable endpoints—including “immunobridging,” a controversial method that infers effectiveness based on antibody levels rather than direct evidence that the vaccine prevents disease.
The clinical trial data submitted by Pfizer and Moderna reveal significant design flaws, including the shockingly low number of trial participants who actually contracted COVID-19, making it impossible to demonstrate meaningful protection. In fact, Moderna’s own trial showed more COVID-19 cases in the vaccinated group than in the placebo group among infants under six months of age.
Serious adverse events, including fever, irritability, vomiting, diarrhea, and myocarditis, were largely dismissed as insignificant. Rather than addressing these concerns, regulators moved forward aggressively. The FDA granted Emergency Use Authorization to both shots for babies as young as six months old. Days later, the CDC endorsed the vaccines, assuring the public they were “safe and effective”—despite clear evidence to the contrary.
Despite the Biden administration’s relentless promotion, uptake of COVID-19 vaccines in young children has remained abysmally low. Parents, it seems, have been far more cautious than government agencies.
If Kennedy proceeds with removing the COVID-19 vaccines from the childhood schedule, it would mark a significant victory for medical freedom advocates—and a severe blow to the pharmaceutical industry, which has seen the shots become a cash cow even as public trust in them plummets.
The decision would also expose the troubling conflicts of interest that have long plagued the nation’s vaccine approval process—conflicts Kennedy has spent decades trying to reform.
As America reconsiders the fallout of its pandemic policies, one thing is clear: Under Kennedy’s leadership, business as usual at HHS is over. And for millions of parents across the country, that change cannot come soon enough.
